Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Plus Tenofovir vs Adefovir Added to Lamivudine in Resistant HBV
NCT00605384Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Aug 2008; status: terminated.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00605384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605384.